Visceral Obesity Promotes Lung Cancer Progression – Towards Resolution of the Obesity Paradox in Lung Cancer
by Christina Black | May 26, 2021

Tumor inflammatory signature as a biomarker of response to immunotherapy in lung cancer
by Christina Black | Jun 19, 2020
View the published article
Lung Cancer Mutational Profile Correlates with Immune Profile
by OmniSeq Staff | Jan 13, 2018
Follow Us on Twitter
LABCORP EXPANDS ACCESS TO COMPREHENSIVE GENOMIC TESTING THROUGH NEW LUNG CANCER PROGRAM UTILIZING OmniSeq INSIGHT
https://tinyurl.com/59xf82c6
@OmniSeq
@Labcorp
#oncology
#precisionmedicine
Last year, the Buffalo-based cancer diagnostics firm @OmniSeq quietly was acquired by one of the world's largest life science companies, @Labcorp . Developing molecular diagnostic tests for cancer patients, OmniSeq is looking to scale its operations.
https://tinyurl.com/muxryphz